<

 
Data updated 2025-04-25 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date16757165.2 (espacenet)  (Federated)  (European Patent Register), 20160805
Patent/reg. no. and dateDK/EP 3331915, 20210217
Publication date20180613
Priority no. and dateUS 201562201461 P, 20150805
EP pub. no. and date EP 3331915 20180613
Effective date
Applicant/ownerAmgen Research (Munich) GmbH, Staffelseestrasse 2
81477 München, DE
Applicant ref. no.1579097
InventorFIEDLER, Walter, Husumerstrasse 8
20251 Hamburg, DE,
WELLBROCK, Jasmin, Brucknerstrasse 31a
22083 Hamburg, DE,
STAMM, Hauke, Hallerstrasse 1a
20146 Hamburg, DE,
KLINGLER, Felix, Klecker Weg 14a
21244 Buchholz, DE
RepresentativeRWS Group, RWS Compass House Vanwall Business Park, Vanwall Road Maidenhead, Berkshire SL6 4UB , GB
Opponent
IPC ClassA61K 39/395 (2006.01) , A61P 35/02 (2006.01) , C07K 16/28 (2006.01) , G01N 33/574 (2006.01) 
TitleIMMUN-CHECKPOINT-INHIBITORER TIL ANVENDELSE TIL BEHANDLING AF BLODBÅRNE CANCERE
Int. application no.EP2016068726
Int. publication no.WO2017021526
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact